The premier meeting-place for the Clinical Trials sector in Central & Eastern Europe

28-29 May 2019

Hotel Bristol, Vienna

Conference Agenda - Day 1

Day 1


Back to Agenda Page'
Registration and Morning Coffee

Back to Agenda Page'
Welcome speech from Adam Smith Conferences

Back to Agenda Page'
Keynote Presentation: Future trends and changes in the landscape of the Clinical Trials market globally and in the CEE region


A review of the future landscape of global clinical trials and perspectives for the CEE region. Insights into trends and projections (in biotech, genome diagnosis, gene therapy, personalised medicine, etc). Global factors affecting clinical trials in CEE: how can the region strengthen its competitive advantage?


Back to Agenda Page'
The Latest Regulatory Changes Impacting Clinical Trials in CEE
  • The latest regulatory changes: how will they be applied in practice?
  • How far will the EU Clinical Trial Regulation No. 536/2014 streamline the regulatory process of CT in CEE? 
  • The Health Technology Assessment (HTA): An overview of the HTA and its role in clinical trials. What is the clinical effectiveness of the HTA? What's the future of HTA data?
  • The new European Data Privacy Regulation: what is the experience to date and the impact on implementing Clinical Trials?
  • Adherence to the GCP rules ICH GCP E6 (R2): How are the rules being enforced? How important are these rules for Clinical Trials?
  • EU Clinical Trial Regulation
Francis Crawley
Executive Director
Good Clinical Practice Alliance - Europe (GCPA), Belgium
Strategic Initiative for Developing Capacity in Ethical Review
(SIDCER), Belgium
Masha Komnenic
Information Security and Data Privacy Specialist | Certified Data Protection Officer (CIPP/E AND PECB DPO)
Axiom International

Back to Agenda Page'
Session 1: Geographic Trends in Clinical Trials in CEE countries: a comparative analysis of challenges and opportunities across the region
  • CT in Poland, Czech Republic, Hungary, Bulgaria, Baltic countries, Turkey, Romania, Ukraine and Belarus etc.
  • Analysis of the speed of patient enrolment in the CEE region: KPIs
  • Country selection for Clinical Trials – key factors and performance benchmarking: costs, quality, growth prospects
  • Current network status in CEE: development of platforms for facilitating partnerships in the region?
Beata Cecetkova
Clinical Research Director
TWMA Clinical Research and Pharmacovigilance, Czech Republic
Radu Costin Ganescu
National Coalition of organisations for patients with chronic conditions of Romania (COPAC)
European Patients Forum
Innovative strategies in investigator-initiated clinical research: the Hungarian experience
Gabor L. Kovacs
University of Pécs, Szentagothai Research Centre, Academy of Science Hungary
Maja Conkic
Vice President
Association for Advancement of Clinical Research of Serbia KLINIS
Managing Director
Axiom International
Roman Serguchev
Clinical Trial Manager
Avva Rus (AVVA Pharmaceuticals AG)

Back to Agenda Page'
Coffee & Networking Break

Back to Agenda Page'
Keynote Presentation – Will Real World Evidence Revolutionise the Clinical Trials’ Sector?
  • What are the pros and cons of incorporating RWE in CT?
  • RWE in CT planning: how to optimise clinical trial design and patient recruitment using real world evidence?
  • What are the obstacles to utilising RWE? Access to data, lack of standardisation in data analytics
Deyan Mehandjiev

Back to Agenda Page'

Back to Agenda Page'
Session 2: Logistics and Supply Chain in Clinical Trials

How to develop better practices and implement new technologies for a clinical trial supply chain in CEE countries?

How to overcome potential operational challenges in clinical trials?

The ways Air Cargo industry can improve the handling of pharmaceutical shipments



Francisco Rizzuto
Cargo Specialist Manager for Europe
International Air Transport Association (IATA)
Raffaele Laciti
Product Manager, Clinical Trial Supply
World Courier

Back to Agenda Page'
Session 3: Panel Discussion: Innovations and New Technologies in Clinical Trials – How to leverage new technologies to advance clinical research?
  • The use of sensors, IoT and Big Data analytics in CT – what are the possibilities?
  • Enhancing information exchange between patients and clinical trials (mHealth,  mobile devices and wearable technologies in clinical trials) – the benefits and challenges of utilisation?
  • Risk-based management and monitoring: trends and technologies
  • Introduction of Remote Monitoring: pros and cons
  • Blockchain in CT
  • Machine-Learning & Artificial Intelligence in clinical trials – emerging applications to improve CT efficiency: experience of implementation to date
Eddie Guzdar
Medical Head - Neuroscience
Sanofi Genzyme UKIE
Alain Bindels
Head of Innovation Facilitation
Isabelle Naeije
Assoc. Global Trial Director
Balázs Bende
M.D., Professional leader at Clinical Research Coordination Centre
University of Szeged

Back to Agenda Page'
Coffee & Networking Break

Back to Agenda Page'
1-to-1 meetings with Pharma Companies, Biotech and CROs


1-to-1 meetings offer an invaluable opportunity to meet and collaborate with pharma & biotech executives and CROs - in person. Leading companies will be represented by their clinical research specialists. Meetings will last 10 minutes, allowing you to introduce your company and service, align your offerings, and establish direct contact with top managers for future collaboration.

The number of meetings available is limited. Register your delegate place early for priority in booking meeting slots with Pharma, Biotech and CRO leaders!



Back to Agenda Page'
Cocktail & Networking Reception
For Speaker Opportunities Please Contact: Diana Koumi: Tel: +44 7507744603